4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001415889-23-005764
Options or other derivatives
- SVP, FINANCE AND ACCOUNTING acquired 55,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Brennan Kevin M. SVP, FINANCE AND ACCOUNTING | 2023-04-01 | Grant or award · Stock Option (right to buy) | +55,000 | 55,000 | D | ||
Loading xslF345X04/form4-04032023_080434.xml…